
Simplex Castings Q2 FY27: standalone PAT up 37% YoY to ₹7.64 Cr, OPM expands to 20.2%
Simplex Castings' standalone PAT rose 36.98% year-on-year to ₹7.64 Cr on revenue of ₹63.01 Cr (+13.71% YoY), with sequential moves far milder at +3.38% revenue and +11.41% PAT QoQ — the YoY print is what matters here since this is a small industrial-castings business without meaningful seasonality. As a micro-cap with no analyst coverage, there is no formal Street consensus to grade the print against; a web search turned up no brokerage estimates for this quarter, so vsStreet is genuinely unknown rather than assumed. Profitability improved on both margin lines: operating margin (OPM) expanded to 20.23% from 17.42% a year ago and 18.89% last quarter, while net margin (NPM) rose to 12.13% from 10.00% YoY and 11.24% QoQ. The expansion sits mainly on the materials line — raw-material consumption plus inventory movement came to ₹43.13 Cr versus ₹38.85 Cr a year earlier on 13.7% higher revenue, a sub-proportionate rise — while employee and other operating costs scaled roughly in line with revenue. Management's FY27 guidance from the Q1 concall called for ₹300 Cr revenue and ~11-12% NPM; H1FY27 revenue of ₹123.96 Cr is 41% of that target and Q2's 12.13% NPM sits at the top of the guided band, so the quarter reads as on-plan to slightly ahead, not a blowout beat or a miss. The quarter's other newsflow is capital-raise and management-continuity rather than operating. The company allotted equity/warrants worth ₹8.0 Cr (Nov 6) and a further ₹18.69 Cr (Nov 12), days after BSE's in-principle approval for the preferential issue (Nov 3); paid-up capital rose to ₹8.20 Cr from ₹7.77 Cr a year ago and weighted-average shares grew 5.5% YoY, which is why EPS growth (+30% YoY on the split-adjusted ₹1.43 base) trails PAT growth. The proceeds line up with capital work-in-progress nearly tripling to ₹36.77 Cr from ₹12.38 Cr at FY26-end — consistent with the capacity build management has said it needs to reach its FY28 ₹500 Cr target (requiring organic growth to ₹300-350 Cr plus inorganic additions). Separately, CFO Rajesh Kumar Acharya's medical-grounds resignation (Nov 7) was withdrawn and accepted back at the same Nov 13 board meeting that approved these results, closing out a week of uncertainty with no continuity gap. Hitting the ₹300 Cr FY27 target now needs roughly ₹176 Cr of revenue in H2 against ₹124 Cr in H1 — a step-up of about 42% half-on-half — so execution against the ₹130+ Cr order book flagged at the Q1 call, and progress on the railways (₹50 Cr target) and power (₹100 Cr target) segments management called out, are the markers for next quarter.
Key Highlights
- Standalone revenue ₹63.01 Cr, up 13.71% YoY (₹55.41 Cr) and 3.38% QoQ (₹60.95 Cr).
- Standalone PAT ₹7.64 Cr, up 36.98% YoY (₹5.58 Cr) and 11.41% QoQ (₹6.86 Cr); EPS ₹1.86 vs split-adjusted ₹1.43 a year ago (+30.07%).
- OPM expanded to 20.23% from 17.42% YoY and 18.89% QoQ; NPM rose to 12.13% from 10.00% YoY and 11.24% QoQ — both at or above management's ~11-12% NPM guidance band.
- H1FY27 revenue of ₹123.96 Cr is 41% of the FY27 ₹300 Cr target, backed by an order book that crossed ₹130 Cr in Q1FY27.
- Capital work-in-progress nearly tripled to ₹36.77 Cr (from ₹12.38 Cr at FY26-end), funded partly by two preferential allotments of equity/warrants worth ₹18.69 Cr (Nov 12) and ₹8.0 Cr (Nov 6), following BSE's in-principle approval (Nov 3).
- Weighted average shares rose 5.5% YoY to 4.10 Cr post the preferential allotments, diluting EPS growth below PAT growth.
- CFO Rajesh Kumar Acharya's medical-grounds resignation (Nov 7) was withdrawn the same week (Nov 13), with no break in service.
Price Impact
More from SIMPLEXCAS